Find clinical trials for Roche. Search for Roche clinical trials in different cities and states across the United States.
Filter
Filter results
Results: 150
Active & Responsive
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
for
Non-Hodgkin Lymphoma
Location: Charlotte NC, Tampa FL, Chicago IL, Houston TX,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT05169515
Phase1, Recruiting
Active & Responsive
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy
for
Muscular Atrophy, Spinal
Location: Philadelphia PA, Norfolk VA, Gainesville FL, Atlanta GA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 0 - 2
Code: NCT05861999
Recruiting
Active & Responsive
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors
for
ALK Fusion-positive Solid or CNS Tumors
Location: Montreal, Toronto, St. Petersburg FL, Ann Arbor MI,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 0 - 17
Code: NCT04774718
Phase1, Phase2, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis
Renal Denervation + PVI vs PVI Alone for Persistent AF
for
Atrial Fibrillation
Location: Short Hills NJ
Sponsor: University of Rochester
Sex: All
Age: 18+
Code: NCT05116384
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
for
Moderately to Severely Active Ulcerative Colitis
Location: Providence RI, Lebanon NH, North Massapequa NY,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06588855
Phase3, Recruiting
Active & Responsive
A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts
for
Influenza
Location: Miami FL, Charleston SC, Smithfield PA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 0 - 11
Code: NCT06094010
Phase3, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
for
Primary IgA Nephropathy
Location: Sydney, Boston MA, Quebec, Mineola NY, Montreal,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT05797610
Phase3, Recruiting
Active & Responsive
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
for
Metastatic Colorectal Cancer
Location: Port Jefferson Station NY, New Haven CT,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT04929223
Phase1, Recruiting
Active & Responsive
A Trial of Dyanavel XR in Treating Co-occurring Fatigue Symptoms in Adults With Attention Deficit Hyperactivity Disorder (ADHD).